Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Whitehawk Therapeutics, Inc. (WHWK) had Stock-Based Compensation of $9.87M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-23.25M |
|
-- |
|
-- |
|
$24.89M |
|
$-24.89M |
|
$1.64M |
|
$-23.25M |
|
$-23.25M |
|
$-23.25M |
|
$-23.25M |
|
$-23.25M |
|
$-23.25M |
|
$-24.89M |
|
$-25.72M |
|
61.89M |
|
61.89M |
|
$-1.15 |
|
$-1.14 |
|
| Balance Sheet Financials | |
$149.01M |
|
$0.00M |
|
$1.82M |
|
$150.83M |
|
$14.52M |
|
-- |
|
-- |
|
$14.52M |
|
$136.31M |
|
$136.31M |
|
$136.31M |
|
47.15M |
|
| Cash Flow Statement Financials | |
$-97.43M |
|
$11.89M |
|
$94.38M |
|
$28.73M |
|
$37.57M |
|
$8.83M |
|
|
Stock-Based Compensation |
$9.87M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.26 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-97.98M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-17.06% |
|
-17.06% |
|
-15.42% |
|
-17.06% |
|
$2.89 |
|
$-1.58 |
|
$-1.57 |
|